Fight Illicit Pill Presses Act
- Sponsor
- Rep. Hageman, Harriet M. [R-WY-At Large]
- Committees
- Judiciary Committee (primary)
- Last action
- Jul 15, 2026
Bottom line
This bill aims to combat the illicit production of counterfeit pills, particularly those containing fentanyl, by increasing traceability and accountability for the machines used to manufacture them.
What it actually does
This bill amends the Controlled Substances Act to expand the definition of "regulated person" to include those who manufacture, distribute, import, or export tableting machines, encapsulating machines, or their critical parts. It mandates that these machines and parts be identified with permanent serial numbers and that transactions involving them be reported to the Attorney General. Furthermore, the bill makes it a federal crime to remove, alter, or obliterate these serial numbers or to possess such machines with knowledge of altered serial numbers.
Proponents argue
Supporters argue that this bill is a crucial step in the fight against the fentanyl crisis and the proliferation of counterfeit pills. By requiring serial numbers on pill presses and their critical components, and making it a crime to tamper with them, law enforcement will have enhanced tools to track the origin of illicit drug manufacturing equipment, disrupt supply chains, and hold accountable those who facilitate the production of dangerous drugs. This measure closes a loophole that allows these machines to operate anonymously in the illicit market.
Opponents contend
Critics might argue that while the intent is laudable, the bill could impose undue regulatory burdens on legitimate manufacturers and distributors of tableting and encapsulating machines, which have many legal industrial and pharmaceutical uses. They might also contend that sophisticated illicit operations could find ways around these requirements, such as manufacturing their own parts or acquiring machines from unregulated international sources, thus shifting the problem rather than solving it. Some may also raise concerns about the potential for overreach in criminalizing possession of machines with altered serial numbers, depending on the specifics of enforcement.
The bill is very short and straightforward, making it highly accessible for a reader to understand its core provisions quickly.
Section 2(a)
Expansion of "Regulated Person" Definition and New Definitions
This section expands the scope of who is considered a "regulated person" under the Controlled Substances Act. Previously, this primarily referred to those dealing with listed chemicals. Now, it includes anyone who manufactures, distributes, imports, or exports tableting machines, encapsulating machines, or their "critical parts" (like punches and dies). It also defines these critical parts, ensuring clarity on what components are subject to regulation.
Supporters argue
Supporters argue that expanding the definition of "regulated person" is essential to bring the tools of illicit drug manufacturing under federal oversight. This ensures that the entire supply chain for pill presses, which are often used to create counterfeit pills containing dangerous substances like fentanyl, is subject to scrutiny, making it harder for these machines to fall into the wrong hands.
Critics contend
Some critics might argue that expanding the definition to include legitimate machine manufacturers and distributors could create unnecessary administrative hurdles and costs for businesses that are not involved in illicit activities. They might contend that this broadens the scope of federal regulation beyond what is strictly necessary to target criminal enterprises.
Tradeoffs
The bill balances the need for enhanced law enforcement tools to combat illicit drug manufacturing with the potential for increased compliance costs and regulatory burdens on legitimate industries.
Section 2(b)
Serial Number Requirement and Reporting
This provision mandates that all newly manufactured, distributed, delivered, sold, imported, or exported tableting machines, encapsulating machines, and their critical parts must have a unique serial number permanently affixed. These serial numbers, along with transaction details, must be reported to the Attorney General. The Attorney General is also required to issue regulations, including guidance for how machines manufactured *before* the bill's enactment should be handled, within 180 days.
Section 2(c)
Prohibited Acts Related to Serial Numbers
This section amends the Controlled Substances Act to make it a federal crime to remove, alter, or obliterate the required serial numbers on tableting machines, encapsulating machines, or their critical parts. it also criminalizes the transportation, shipment, receipt, possession, distribution, delivery, sale, import, or export of such machines or parts if one knows the serial number has been removed, altered, or obliterated, and has reasonable cause to believe it was required.
The bill requires the Attorney General to issue detailed guidance on serial numbers for tableting machines, encapsulating machines, or critical parts manufactured on or before the date of enactment. It also states that serial numbers affixed according to this guidance will be deemed required.
Section 2(b)(3)(B) and (C)
Why it matters:This is standard legislative practice to address transitional issues and ensure existing equipment can be brought into compliance without requiring retroactive physical alteration of every machine.
Case for: Supporters would argue this is a practical and necessary provision to ensure that the bill's intent to track illicit presses is not limited to only new machines. It provides a pathway for existing equipment, which could still be diverted to illicit uses, to be brought under the regulatory framework, enhancing overall traceability.
Case against: Critics might argue that retroactively applying serial number requirements, even through guidance, could be complex and costly for businesses that have older equipment. There could be challenges in verifying the authenticity or origin of serial numbers applied to older machines, potentially creating loopholes or administrative burdens without commensurate enforcement benefits.
Estimated impact: Potentially significant administrative effort for both industry and the Attorney General to develop and implement guidance for existing inventory.